Search
National Medical Products Administration: Robust Backing for Biomanufacturing Industry's Innovative Growth in the 15th Five-Year Plan Era
1 day ago /
Read about 0 minute
Author：小编
On February 4, 2026, at the National Conference on Drug Registration Management and Post-Marketing Supervision held in Nanjing, reporters were informed that throughout the 15th Five-Year Plan period, China is set to strongly bolster the innovative progress of the biomanufacturing sector. The nation aims to drive three significant shifts within the pharmaceutical industry: transitioning from "follower-style innovation" to "systematic innovation," from "growth focused on scale and speed" to "growth centered on quality and efficiency," and from "conventional business models" to "supply chain digitalization" models.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
